Head, neck cancer trial shows assessing HRQOL is valuable to patients, doctors
Wednesday, November 20, 2013 - 15:30
in Health & Medicine
EORTC trial 24954 set out to compare two treatment schemes for patients with respectable hypopharyngeal and laryngeal cancers, and the results show that there is a trend towards worse HRQOL scores in patients receiving alternating chemoradiotherapy (Alternating arm) as opposed to those given sequential induction chemotherapy and radiotherapy (Sequential arm). However, very few differences reached the level of statistical significance, and most patients' HRQOL scores returned to baseline once treatment was completed.